1. Home
  2. SNOA vs DUO Comparison

SNOA vs DUO Comparison

Compare SNOA & DUO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNOA
  • DUO
  • Stock Information
  • Founded
  • SNOA 1999
  • DUO 2011
  • Country
  • SNOA United States
  • DUO China
  • Employees
  • SNOA N/A
  • DUO N/A
  • Industry
  • SNOA Biotechnology: Pharmaceutical Preparations
  • DUO Real Estate
  • Sector
  • SNOA Health Care
  • DUO Finance
  • Exchange
  • SNOA Nasdaq
  • DUO Nasdaq
  • Market Cap
  • SNOA 7.5M
  • DUO 6.1M
  • IPO Year
  • SNOA 2007
  • DUO 2019
  • Fundamental
  • Price
  • SNOA $4.55
  • DUO $4.29
  • Analyst Decision
  • SNOA
  • DUO
  • Analyst Count
  • SNOA 0
  • DUO 0
  • Target Price
  • SNOA N/A
  • DUO N/A
  • AVG Volume (30 Days)
  • SNOA 3.9M
  • DUO 5.1M
  • Earning Date
  • SNOA 11-06-2025
  • DUO 08-29-2025
  • Dividend Yield
  • SNOA N/A
  • DUO N/A
  • EPS Growth
  • SNOA N/A
  • DUO N/A
  • EPS
  • SNOA N/A
  • DUO N/A
  • Revenue
  • SNOA $14,912,000.00
  • DUO $56,189,313.00
  • Revenue This Year
  • SNOA $23.00
  • DUO N/A
  • Revenue Next Year
  • SNOA $24.59
  • DUO N/A
  • P/E Ratio
  • SNOA N/A
  • DUO N/A
  • Revenue Growth
  • SNOA 17.43
  • DUO 48.30
  • 52 Week Low
  • SNOA $1.75
  • DUO $1.24
  • 52 Week High
  • SNOA $6.92
  • DUO $74.72
  • Technical
  • Relative Strength Index (RSI)
  • SNOA 55.76
  • DUO 79.61
  • Support Level
  • SNOA $4.45
  • DUO $1.46
  • Resistance Level
  • SNOA $4.74
  • DUO $3.25
  • Average True Range (ATR)
  • SNOA 0.27
  • DUO 0.54
  • MACD
  • SNOA -0.07
  • DUO 0.29
  • Stochastic Oscillator
  • SNOA 16.38
  • DUO 92.13

About SNOA Sonoma Pharmaceuticals Inc.

Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.

About DUO Fangdd Network Group Ltd.

Fangdd Network Group Ltd is an investment holding company. It is engaged in the provision of real estate information services through its online platform which also offers integrated marketing services for individual customers, real estate developers, and agents in China. Its SaaS-based solutions help real estate agents to connect with essential business resources, including customers, property listings, capital, and transaction data. The company generates the majority of its revenue from Base commission from transactions in China.

Share on Social Networks: